Apart from the pegylated-FVIIa that NVO is developing with NTEC, NVO is developing an enhanced FVIIa called NN1731 that is further along in development than the product licensed from NTEC. Please see #msg-18366299 and #msg-18366317. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.